Extracorporeal Treatment of Cast Nephropathy

Seminars in Dialysis

Volumn 24, Issue 1, 2011, Pages 9-11

  Gakhar, Bhavna ^a   Kobrin, Sidney ^a   Berns, Jeffrey S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN;

ARTICLE; BLOOD; HUMAN; KIDNEY DISEASE; METHODOLOGY; MULTIPLE MYELOMA; PLASMAPHERESIS; TREATMENT OUTCOME;

HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; KIDNEY DISEASES; MULTIPLE MYELOMA; PLASMA EXCHANGE; TREATMENT OUTCOME;

EID: 79951799585     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2010.00814.x     Document Type: Article

References (20)

1. Knudsen LM, Hjorth M, Hippe E: Renal failure in multiple myeloma: Reversibility and impact on the prognosis. Nordic Myeloma Study Group. Eur J Haematol 65:175-181, 2000
2. Blade J, Fernandez-Llama P, Bosch F, Montoliu J, Lens XM, Montoto S, Cases A, Darnell A, Rozman C, Montserrat E: Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med 158: 1889-1893, 1998
3. Eleutherakis-Papaiakovou V, Bamias A, Gika D, Simeonidis A, Pouli A, Anagnostopoulos A, Michali E, Economopoulos T, Zervas K, Dimopoulos MA; Greek Myeloma Study Group: Renal failure in multiple myeloma: incidence, correlations, and prognostic significance. Leuk Lymphoma 48:337-341, 2007
4. Rayner HC, Haynes AP, Thompson JR, Russell N, Fletcher J: Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single center between 1975 and 1988. QJ Med 79: 517-525, 1991
5. Kyle RA, Gertz MA, Witzig TE, Lust JA, Lacy MQ, Dispenzieri A, Fonseca R, Rajkumar SV, Offord JR, Larson DR, Plevak ME, Therneau TM, Greipp PR: Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc 78:21-33, 2003
6. Herrera GA, Joseph L, Gu X, Hough A, Barlogie B: Renal pathologic spectrum in an autopsy series of patients with plasma cell dyscrasia. Arch Pathol Lab Med 128:875-879, 2004
7. Bouvet JP, Frot JC, Ducaylar A, Benlarhache C, Muller F: Gammopathies with oligoclonal electrophoretic patterns. Incidence, immunochemical nature and association with neoplastic pathology. Presse Med 12: 2511-2514, 1983
8. Sanders PW, Brooker BB: Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest 89:630-639, 1992
9. Sanders PW, Herrera GA, Kirk KA, Old CW, Galla JH: Spectrum of glomerular and tubulointerstitial renal lesions associated with monotypical immunoglobin light chain deposition. Lab Invest 64:527-537, 1991
10. Pillon L, Sweeting R, Arora A, Notkin A, Ballard H, Wieczorek RL, Leung N: Approach to acute renal failure in biopsy proven myeloma cast nephropathy: is there a role of plasmapharesis? Kidney Int 74:956-961, 2008
11. Zucchelli P, Pasquali S, Cagnoli L, Ferrari G: Controlled plasma exchange trial in acute renal failure due to multiple myeloma. Kidney Int 33:1175-1180, 1988
12. Leung N, Gertz MA, Zeldenrust SR, Rajkumar SV, Dispenzieri A, Fervenza FC, Kumar S, Lacy MQ, Lust JA, Greipp PR, Witzig TE, Hayman SR, Russell SJ, Kyle RA, Winters JL: Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains. Kidney Int 73:1282-1288, 2008
13. Johnson WJ, Kyle RA, Pineda AA, O'Brien PC, Holley KE: Treatment of renal failure associated with multiple myeloma. Plasmapheresis, hemodialysis, and chemotherapy. Arch Intern Med 150:863-869, 1990
14. Clark WF, Stewart AK, Rock GA, Sternbach M, Sutton DM, Barrett BJ, Heidenheim AP, Garg AX, Churchill DN, Canadian Apheresis Group: Plasma exchange when myeloma presents as acute renal failure. A randomized, controlled trial. Ann Intern Med 143:777-784, 2005
15. Winearls CG: Acute myeloma kidney. Kidney Int 48:1347-1361, 1995
16. Durie BG, Kyle RA, Belch A, Bensinger W, Blade J, Boccadoro M, Child JA, Comenzo R, Djulbegovic B, Fantl D, Gahrton G, Harousseau JL, Hungria V, Joshua D, Ludwig H, Mehta J, Morales AR, Morgan G, Nouel A, Oken M, Powles R, Roodman D, San Miguel J, Shimizu K, Singhal S, Sirohi B, Sonneveld P, Tricot G, Van Ness B; Scientific Advisors of the International Myeloma Foundation: Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J 4:379-398, 2003
17. Ward RA: Protein-leaking membranes for hemodialysis: a new class of membranes in search of an application. J Am Soc Nephrol 16:2421-2430, 2005
18. Hutchison CA, Cockwell P, Reid S, Chandler K, Mead GP, Harrison J, Hattersley J, Evans ND, Chappell MJ, Cook M, Goehl H, Storr M, Bradwell AR: Efficient removal of immunoglobulin free light chains by hemodialysis for multiple myeloma: in-vitro and in-vivo studies. J Am Soc Nephrol 18:886-895, 2007
19. Hutchison CA, Bradwell AR, Cook M, Basnayake K, Basu S, Harding S, Hattersley J, Evans N, Chappel M, Sampson P, Foggensteiner L, Adu D, Cockwell P: Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis. Clin J Am Soc Nephrol 4:745-754, 2009
20. Hutchison CA, Cook M, Heyne N, Weisel K, Billingham L, Bradwell A, Cockwell P: European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy (EuLITE): a randomised controlled trial. Trials 9:55, 2008